Respiratory infections like influenza, RSV (respiratory syncytial virus), and now COVID-19, among others, place a substantial and growing burden on health systems. Among these three infections—responsible for the so called “tripledemic”—RSV is the least recognized. There is low awareness of RSV among healthcare professionals and the general public and little understanding of the disease burden and impact in older adults globally, but particularly in the Asia-Pacific region—which is rapidly aging.
This report, released in April 2024, shares four key takeaways from this roundtable, culminating in a set of calls to action, including the need to establish a an Asia-Pacific RSV consortium to enhance data surveillance and support planning and decision-making in the region.